Siping Huang

Siping Huang

Auto-generated profile, based on publicly available information

Siping Huang

Department of Biomedical Engineering, College of Biomedicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in ACS Nano
Verified
Journal Article
Closed access
Yuankai JinYuankai Jin
Yuankai Jin
XLXiaonan Liu
Xiaonan Liu
WXWanghuai Xu
Wanghuai Xu
PSPengcheng Sun
Pengcheng Sun
SHSiping Huang
Siping Huang
Zuankai WangZuankai Wang
Zuankai Wang

1 September 2022 in Matter
Verified
Journal Article
Closed access
JSJames Utama Surjadi
James Utama Surjadi
YZYongsen Zhou
Yongsen Zhou
SHSiping Huang
Siping Huang
LWLiqiang Wang
Liqiang Wang
Maoyuan LiMaoyuan Li
Maoyuan Li
Yang LuYang Lu
Yang Lu

22 September 2024 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
CLCia-Hin Lau
Cia-Hin Lau
SHSiping Huang
Siping Huang
HZHaibao Zhu
Haibao Zhu
CRISPR-based diagnostics (CRISPR/Dx) have revolutionized the field of molecular diagnostics. It enables home self-test, field-deployable, and point-of-care testing (POCT). Despite the great potential of CRISPR/Dx in diagnoses of biologically complex diseases, preamplification of the template often is required for the sensitive detection of low-abundance nucleic acids. Various amplification-free CRISPR/Dx systems were recently developed to enhance signal detection at sufficient sensitivity. Broadly, these amplification-free CRISPR/Dx systems are classified into five groups depending on the signal enhancement strategies employed: CRISPR/Cas12a and/or CRISPR/Cas13a are integrated with: (1) other catalytic enzymes (Cas14a, Csm6, Argonaute, duplex-specific nuclease, nanozyme, or T7 exonuclease), (2) rational-designed oligonucleotides (multivalent aptamer, tetrahedral DNA framework, RNA G-quadruplexes, DNA roller machine, switchable-caged guide RNA, hybrid locked RNA/DNA probe, hybridized cascade probe, or "U" rich stem-loop RNA), (3) nanomaterials (nanophotonic structure, gold nanoparticle, micromotor, or microbeads), (4) electrochemical and piezoelectric plate biosensors (SERS nanoprobes, graphene field-effect transistor, redox probe, or primer exchange reaction), or (5) cutting-edge detection technology platforms (digital bioanalysis, droplet microfluidic, smartphone camera, or single nanoparticle counting). Herein, we critically discuss the advances, pitfalls and future perspectives for these amplification-free CRISPR/Dx systems in nucleic acids detection. The continued refinement of these CRISPR/Dx systems will pave the road for rapid, cost-effective, ultrasensitive, and ultraspecific on-site detection without resorting to target amplification, with the ultimate goal of establishing CRISPR/Dx as the paragon of diagnostics.

3 November 2025 in Langmuir
Verified
Journal Article
Closed access
JRJifeng Ren
Jifeng Ren
SHShuhuan Hu
Shuhuan Hu
YLYi Liu
Yi Liu
SHSiping Huang
Siping Huang
JZJingqian ZHANG
Jingqian ZHANG
Raymond LamRaymond Lam
Raymond Lam